fluconazole has been researched along with Infections, Pseudomonas in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a patient with multiple myeloma, numerous indurated, subcutaneous nodules and pyomyositis due to Pseudomonas aeruginosa were noted." | 1.28 | Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage. ( Akoglu, T; Bayik, M; Firatli, T; Gürbüz, O; Korten, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaheer, Z | 1 |
| Khan, FA | 1 |
| Sangshetti, JN | 1 |
| Patil, RH | 1 |
| Lohar, KS | 1 |
| Quintela Obregón, E | 1 |
| Palomar Fontanet, R | 1 |
| Salas, C | 1 |
| Rodrigo Calabia, E | 1 |
| Arias Rodríguez, M | 1 |
| Florescu, DF | 1 |
| Grant, W | 1 |
| Botha, JF | 1 |
| Fey, P | 1 |
| Kalil, AC | 1 |
| Kalavsky, E | 1 |
| Kisac, P | 1 |
| Huttova, M | 1 |
| Benca, J | 1 |
| Krcmery, V | 1 |
| Xie, W | 1 |
| Li, X | 1 |
| Alter, SJ | 1 |
| Farley, J | 1 |
| Elewski, BE | 1 |
| Korten, V | 1 |
| Gürbüz, O | 1 |
| Firatli, T | 1 |
| Bayik, M | 1 |
| Akoglu, T | 1 |
8 other studies available for fluconazole and Infections, Pseudomonas
| Article | Year |
|---|---|
Novel amalgamation of phthalazine-quinolines as biofilm inhibitors: One-pot synthesis, biological evaluation and in silico ADME prediction with favorable metabolic fate.
Topics: Anti-Infective Agents; Biofilms; Candida albicans; Candidiasis; Computer Simulation; Humans; Phthala | 2016 |
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor].
Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug | 2010 |
Should multivisceral transplantation be considered in patients colonized with multidrug-resistant Pseudomonas aeruginosa?
Topics: Anti-Bacterial Agents; Antifungal Agents; Child, Preschool; Disease Management; Drug Resistance, Mul | 2012 |
Neuroinfections and antimicrobials: do we need new molecules or new strategies?
Topics: Anti-Infective Agents; Brain Diseases; Candidiasis; Cross Infection; Drug Resistance, Microbial; Flu | 2007 |
Experience in treating secondary systemic mycotic infection after severe burns associated with electric injury.
Topics: Adult; Amputation, Surgical; Burns, Electric; Candidiasis; Ciprofloxacin; Fluconazole; Humans; Male; | 1995 |
Development of Hansenula anomala infection in a child receiving fluconazole therapy.
Topics: Accidents, Traffic; Amphotericin B; Blood Transfusion; Candida albicans; Candidiasis; Child, Prescho | 1994 |
Bacterial infection in a patient with onychomycosis.
Topics: Anti-Infective Agents; Antifungal Agents; Ciprofloxacin; Fluconazole; Humans; Male; Middle Aged; Nai | 1997 |
Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage.
Topics: Amikacin; Ceftazidime; Fluconazole; Humans; Male; Middle Aged; Multiple Myeloma; Myositis; Pseudomon | 1992 |